About 50 results
Open links in new tab
  1. Targeted cancer drugs and immunotherapy | Cancer Research UK

    Feb 26, 2025 · Monoclonal antibodies (mAbs) are a type of cancer treatment. They may be called a type of targeted cancer drug or immunotherapy. But they can work in both ways. Find out more.

  2. 301 Moved Permanently

    301 Moved Permanently301 Moved Permanently

  3. Event Volunteer - Cheltenham Race for Life - 28th June 2026

    About the role In every corner of the UK, 400,000 participants are limbering up to join the fight against cancer. Last year, our Race for Life events raised an incredible £26 million, which will …

  4. Treatment options for neuroendocrine cancer - Cancer Research UK

    The most common treatment option for neuroendocrine cancer is surgery. Other treatment options include somatostatin analogues, radiotherapy and chemotherapy.

  5. Help with health costs - Cancer Research UK

    Help with health costs You might be able to get help with the costs of travelling, parking, prescriptions, wigs or special equipment. Travel costs You can get help with travel and …

  6. Cemiplimab | Cancer Information | Cancer Research UK

    Cemiplimab is a type of immunotherapy. It is a treatment for advanced cutaneous squamous cell carcinoma (SCC).

  7. Monmouth - Cancer Research UK

    Find out opening times, what you can donate or how to volunteer at your local shop.

  8. Bowel cancer mortality statistics - Cancer Research UK

    The latest bowel cancer mortality statistics for the UK for Health Professionals. See data for sex, age, trends over time and more.

  9. Cancer survival statistics - Cancer Research UK

    The latest cancer survival statistics for the UK for Health Professionals. See data for sex, age, trends over time and more.

  10. Where to get wigs, hats and scarves - Cancer Research UK

    Where to get wigs, hats and scarves Here are some organisations and suppliers of wigs and other headwear. Remember staff at the hospital will advise you on where to go to choose a wig or …